MT-RNR2 and pneumonia: Although the group immunized with rLS1-HN-RBD developed pathological changes in the lung, those were milder than those seen in the unvaccinated group, showing moderate pneumonia 2 dpc and ending in a moderate to severe pneumonia at 10 days (Fig. 6C).